Clinical features of experimental human infection with haemophilus ducreyi

J. A. Al-Tawfiq, A. C. Thornton, K. A. Fortney, Stanley Spinola

Research output: Contribution to journalArticle

Abstract

Haemophilus ducreyi is the etiologic agent of chancroid, which facilitates the transmission of HIV. The purpose of this study was to standardize the human challenge model of H. ducreyi infection with a human passaged variant of strain 35000 (35000HP). Twenty healthy adult volunteers were challenged with two doses (∼30 cfu) of live and one dose of heat-killed 35000HP inoculated into the skin. Subjects were infected for up to 2 weeks or until they developed a painful or pruritic pustular lesion. Surface cultures were obtained daily. Patients were biopsied and treated with oral ciprofloxacin. Papules developed at 95% (95% CI; 83.1 to 99.4%) of sites infected with live bacteria. Papules resolved spontaneously at 26% of sites. Pustules developed within 2 to 5 days at 70% (95% CI; 47.1 to 86.6%)of sites. In some volunteers, one site resolved while a second site became a pustule, suggesting that local factors play a role in lesion outcome. The recovery rate of H. ducreyi from surface cultures ranged from 13% to 41%. H. ducreyi was recovered from 12 of 15 pustules (80%) and from 1 of 7 papules (14%). The clinical course of experimental infection resembled the initial stages of human chancroid and is biologically relevant, safe, well tolerated and reproducible.

Original languageEnglish
Pages (from-to)478
Number of pages1
JournalClinical Infectious Diseases
Volume25
Issue number2
StatePublished - 1997

Fingerprint

Haemophilus ducreyi
Chancroid
Infection
Haemophilus Infections
Ciprofloxacin
Volunteers
Healthy Volunteers
Hot Temperature
HIV
Bacteria
Skin

ASJC Scopus subject areas

  • Immunology

Cite this

Clinical features of experimental human infection with haemophilus ducreyi. / Al-Tawfiq, J. A.; Thornton, A. C.; Fortney, K. A.; Spinola, Stanley.

In: Clinical Infectious Diseases, Vol. 25, No. 2, 1997, p. 478.

Research output: Contribution to journalArticle

Al-Tawfiq, JA, Thornton, AC, Fortney, KA & Spinola, S 1997, 'Clinical features of experimental human infection with haemophilus ducreyi', Clinical Infectious Diseases, vol. 25, no. 2, pp. 478.
Al-Tawfiq, J. A. ; Thornton, A. C. ; Fortney, K. A. ; Spinola, Stanley. / Clinical features of experimental human infection with haemophilus ducreyi. In: Clinical Infectious Diseases. 1997 ; Vol. 25, No. 2. pp. 478.
@article{743caa7b53da4d118bd60e2dfe684d7e,
title = "Clinical features of experimental human infection with haemophilus ducreyi",
abstract = "Haemophilus ducreyi is the etiologic agent of chancroid, which facilitates the transmission of HIV. The purpose of this study was to standardize the human challenge model of H. ducreyi infection with a human passaged variant of strain 35000 (35000HP). Twenty healthy adult volunteers were challenged with two doses (∼30 cfu) of live and one dose of heat-killed 35000HP inoculated into the skin. Subjects were infected for up to 2 weeks or until they developed a painful or pruritic pustular lesion. Surface cultures were obtained daily. Patients were biopsied and treated with oral ciprofloxacin. Papules developed at 95{\%} (95{\%} CI; 83.1 to 99.4{\%}) of sites infected with live bacteria. Papules resolved spontaneously at 26{\%} of sites. Pustules developed within 2 to 5 days at 70{\%} (95{\%} CI; 47.1 to 86.6{\%})of sites. In some volunteers, one site resolved while a second site became a pustule, suggesting that local factors play a role in lesion outcome. The recovery rate of H. ducreyi from surface cultures ranged from 13{\%} to 41{\%}. H. ducreyi was recovered from 12 of 15 pustules (80{\%}) and from 1 of 7 papules (14{\%}). The clinical course of experimental infection resembled the initial stages of human chancroid and is biologically relevant, safe, well tolerated and reproducible.",
author = "Al-Tawfiq, {J. A.} and Thornton, {A. C.} and Fortney, {K. A.} and Stanley Spinola",
year = "1997",
language = "English",
volume = "25",
pages = "478",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Clinical features of experimental human infection with haemophilus ducreyi

AU - Al-Tawfiq, J. A.

AU - Thornton, A. C.

AU - Fortney, K. A.

AU - Spinola, Stanley

PY - 1997

Y1 - 1997

N2 - Haemophilus ducreyi is the etiologic agent of chancroid, which facilitates the transmission of HIV. The purpose of this study was to standardize the human challenge model of H. ducreyi infection with a human passaged variant of strain 35000 (35000HP). Twenty healthy adult volunteers were challenged with two doses (∼30 cfu) of live and one dose of heat-killed 35000HP inoculated into the skin. Subjects were infected for up to 2 weeks or until they developed a painful or pruritic pustular lesion. Surface cultures were obtained daily. Patients were biopsied and treated with oral ciprofloxacin. Papules developed at 95% (95% CI; 83.1 to 99.4%) of sites infected with live bacteria. Papules resolved spontaneously at 26% of sites. Pustules developed within 2 to 5 days at 70% (95% CI; 47.1 to 86.6%)of sites. In some volunteers, one site resolved while a second site became a pustule, suggesting that local factors play a role in lesion outcome. The recovery rate of H. ducreyi from surface cultures ranged from 13% to 41%. H. ducreyi was recovered from 12 of 15 pustules (80%) and from 1 of 7 papules (14%). The clinical course of experimental infection resembled the initial stages of human chancroid and is biologically relevant, safe, well tolerated and reproducible.

AB - Haemophilus ducreyi is the etiologic agent of chancroid, which facilitates the transmission of HIV. The purpose of this study was to standardize the human challenge model of H. ducreyi infection with a human passaged variant of strain 35000 (35000HP). Twenty healthy adult volunteers were challenged with two doses (∼30 cfu) of live and one dose of heat-killed 35000HP inoculated into the skin. Subjects were infected for up to 2 weeks or until they developed a painful or pruritic pustular lesion. Surface cultures were obtained daily. Patients were biopsied and treated with oral ciprofloxacin. Papules developed at 95% (95% CI; 83.1 to 99.4%) of sites infected with live bacteria. Papules resolved spontaneously at 26% of sites. Pustules developed within 2 to 5 days at 70% (95% CI; 47.1 to 86.6%)of sites. In some volunteers, one site resolved while a second site became a pustule, suggesting that local factors play a role in lesion outcome. The recovery rate of H. ducreyi from surface cultures ranged from 13% to 41%. H. ducreyi was recovered from 12 of 15 pustules (80%) and from 1 of 7 papules (14%). The clinical course of experimental infection resembled the initial stages of human chancroid and is biologically relevant, safe, well tolerated and reproducible.

UR - http://www.scopus.com/inward/record.url?scp=33748132969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748132969&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748132969

VL - 25

SP - 478

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 2

ER -